Literature DB >> 22021712

Epigenetics in diabetic kidney disease.

Marpadga A Reddy1, Rama Natarajan.   

Abstract

Regulated gene expression by transcription factor networks is critical for normal kidney function. Disruption of these complex networks leads to biochemical aberrations associated with many renal diseases. Epigenetic mechanisms not involving changes in DNA sequence, such as DNA methylation and post-translational modifications of nucleosomal histones, also play a critical role in gene regulation by modulating chromatin access to the cellular machinery for transcription. These epigenetic modifications can be affected by intrinsic and extrinsic environmental factors and play a central role in dictating biologic phenotypes including pathologic disease. Emerging evidence also suggests, apart from traditional genetic predisposition, that epigenetic processes can persist across generations to play a modulating role in the development of renal diseases such as diabetic nephropathy. Recent advances in epigenome research has increased our understanding of epigenetic mechanisms involved in renal dysfunction that in turn may lead to identification of novel new therapeutic targets.

Entities:  

Mesh:

Year:  2011        PMID: 22021712      PMCID: PMC3250203          DOI: 10.1681/ASN.2011060629

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

Review 1.  Next-generation genomics: an integrative approach.

Authors:  R David Hawkins; Gary C Hon; Bing Ren
Journal:  Nat Rev Genet       Date:  2010-07       Impact factor: 53.242

Review 2.  Charting histone modifications and the functional organization of mammalian genomes.

Authors:  Vicky W Zhou; Alon Goren; Bradley E Bernstein
Journal:  Nat Rev Genet       Date:  2010-11-30       Impact factor: 53.242

3.  Epigenetic histone methylation modulates fibrotic gene expression.

Authors:  Guangdong Sun; Marpadga A Reddy; Hang Yuan; Linda Lanting; Mitsuo Kato; Rama Natarajan
Journal:  J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 10.121

Review 4.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 5.  The role of epigenetics in the pathology of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

6.  Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Authors:  Uzma F Mehdi; Beverley Adams-Huet; Philip Raskin; Gloria L Vega; Robert D Toto
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

Review 7.  Transcription factors in the pathogenesis of diabetic nephropathy.

Authors:  Amber Paratore Sanchez; Kumar Sharma
Journal:  Expert Rev Mol Med       Date:  2009-04-28       Impact factor: 5.600

8.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

9.  Avosentan for overt diabetic nephropathy.

Authors:  Johannes F E Mann; Damian Green; Kenneth Jamerson; Luis M Ruilope; Susan J Kuranoff; Thomas Littke; Giancarlo Viberti
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

Review 10.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

View more
  33 in total

1.  Managing microvascular complications of diabetes with microRNAs.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

2.  The hyperglycemic and hyperinsulinemic combo gives you diabetic kidney disease immediately. Focus on "Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney".

Authors:  Seung Hyeok Han; Katalin Susztak
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 3.  The role of epigenetics in renal ageing.

Authors:  Paul G Shiels; Dagmara McGuinness; Maria Eriksson; Jeroen P Kooman; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2017-06-19       Impact factor: 28.314

Review 4.  Epigenetic modifications in the pathogenesis of diabetic nephropathy.

Authors:  Marpadga A Reddy; Jung Tak Park; Rama Natarajan
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 5.  Perspectives on systems biology applications in diabetic kidney disease.

Authors:  Claudiu V Komorowsky; Frank C Brosius; Subramaniam Pennathur; Matthias Kretzler
Journal:  J Cardiovasc Transl Res       Date:  2012-06-26       Impact factor: 4.132

Review 6.  The genetics of diabetic complications.

Authors:  Emma Ahlqvist; Natalie R van Zuydam; Leif C Groop; Mark I McCarthy
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 7.  Susceptibility gene search for nephropathy and related traits in Mexican-Americans.

Authors:  Farook Thameem; Issa A Kawalit; Sharon G Adler; Hanna E Abboud
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

8.  Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Authors:  Weier Qi; Hillary A Keenan; Qian Li; Atsushi Ishikado; Aimo Kannt; Thorsten Sadowski; Mark A Yorek; I-Hsien Wu; Samuel Lockhart; Lawrence J Coppey; Anja Pfenninger; Chong Wee Liew; Guifen Qiang; Alison M Burkart; Stephanie Hastings; David Pober; Christopher Cahill; Monika A Niewczas; William J Israelsen; Liane Tinsley; Isaac E Stillman; Peter S Amenta; Edward P Feener; Matthew G Vander Heiden; Robert C Stanton; George L King
Journal:  Nat Med       Date:  2017-04-24       Impact factor: 53.440

9.  Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.

Authors:  Hang Yuan; Marpadga A Reddy; Supriya Deshpande; Ye Jia; Jung Tak Park; Linda L Lanting; Wen Jin; Mitsuo Kato; Zhong Gao Xu; Sadhan Das; Rama Natarajan
Journal:  Antioxid Redox Signal       Date:  2015-11-30       Impact factor: 8.401

Review 10.  Genetic Considerations in Pediatric Chronic Kidney Disease.

Authors:  Lyndsay A Harshman; Diana Zepeda-Orozco
Journal:  J Pediatr Genet       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.